Today, at an听听in Brussels, the Commission is launching the听听to support healthcare providers, research institutes and innovators in making the best use of innovative data-driven solutions for cancer treatment and care. The initiative, a flagship action under听, will work towards creating a听digital infrastructure听linking up resources and databases of cancer imaging data across the EU, while ensuring adherence to high ethics standards, trust, security and protection of personal data. It will also connect EU-level and national initiatives, hospital networks, as well as research repositories with imaging data and other relevant health data.
Technological innovation that is combined with data protection can create a trusted framework for researchers, innovators, doctors, and patients.听Thanks to the new European Cancer Imaging Initiative,听researchers听will have efficient access to more high-quality data to study and advance our understanding of the disease.听Innovators听will be able to develop and test data-driven solutions for cancer care. The facilitation of the development of data-driven solutions will allow听doctors听to make more precise and faster clinical decisions, diagnostics, treatments and predictive medicine, for the benefit of听cancer patients. Furthermore, it will support data altruism from听citizens, who could give their consent or permission voluntarily to make available data that they generate, as a way of enriching the health datasets.
A cross-border, interoperable, and secure infrastructure that will preserve privacy will speed up innovation in medical research. For example, it will be possible to train new technologies that use artificial intelligence (AI) on a large dataset, which is standardised and fully compliant with the General Data Protection Regulation (GDPR). This will speed up the development of innovative tools, which can offer faster cancer diagnosis and improved personalised care.
Advancing health research and care with digital tech
In line with听听and听, the European Cancer Imaging Initiative is one of the flagships of听. It will bring together digital technology innovation and European data protection to create a trusted and secure framework to give researchers, innovators and doctors access to valuable data.
Major European research organisations, institutions, and companies will work together to design the infrastructure that will:
- Give European听clinicians, researchers and innovators听easy access to large amounts of cancer imaging data;
- Support the听testing and development of tools for personalised medicine听to advance cancer diagnostics and treatments;
- Support the听creation of new, and the interoperability of existing, cancer image datasets, in line with the European Strategy for Data.
Next Steps
Following today’s launch of the European Cancer Imaging Initiative with two projects, the听听project and the听听(TEF-Health), it is expected that by December 2023 the design of the pan-European digital infrastructure will have been completed and the collaboration mechanisms will have been established. Data providers will then be able to connect with this new European federated platform. The first version of the platform will be released by the end of 2024 and the final release is expected by the end of 2025. The digital infrastructure will be fully operational and running in 2026.
Background
The EUCAIM project that is under the听听is supported by the听听(DIGITAL) with 鈧�18 million. It is a large-scale project that will deploy the federated European infrastructure of cancer imaging data based on the work accomplished under the 鈥溾��, which is a cluster of 5 projects supported by the Horizon 2020 research programme. The infrastructure aims to include more than 100,000 cancer cases by 2025, and at least 60 million annotated cancer images in a distributed Atlas of cancer images. The project is starting with 21 clinical sites from 12 countries and aims to have at least 30 distributed data providers from 15 countries.
The cancer imaging data will be made available to the听, established under the DIGITAL programme. This will allow small and medium-sized businesses who have developed artificial intelligence solutions for cancer care to test them in real-life environments. Other testing facilities will also be considered.
Furthermore, the听听under the DIGITAL Programme will support the rollout of the technologies relevant for the initiative. They will inform the innovators about the legal requirements and testing facilities available to them. They will also provide a range of services to digital solution users and providers, such as test-before-invest services, training and networking opportunities as well as access to finances.
ec.europa.eu
pixabay
